2018 American Transplant Congress
Alemtuzumab Induction is Effective and Safe in Elderly Kidney Transplant Recipients
University of North Carolina, Chapel Hill.
Purpose of this study is to determine safety of Alemtuzumab (Ab) in elderly kidney recipients.MethodsThis is a retrospective single center cohort analysis concerning kidney transplant…2018 American Transplant Congress
Development of a Screening Tool to Predict Chronic Kidney Disease Risk in Post-Nephrectomy Living Kidney Donors
Purpose: We aimed to develop a prediction models of chronic kidney disease (CKD) for the 1-year period after donor nephrectomy in living donors.Materials and Methods:…2018 American Transplant Congress
Non-Medical Factors Predict Receipt and Type of Kidney Transplant
African Americans have a higher incidence of end-stage kidney disease but lower rates of both deceased and living donor kidney transplant (DDKT and LDKT) compared…2018 American Transplant Congress
The Incidence and Risk Factors for Non – Adherence to Medical Treatment among Patients after Kidney Transplantation
Background: Nonadherence to medical treatment is an important risk factor for acute rejection and graft loss. In this study we sought to determine the prevalence…2018 American Transplant Congress
Greater Susceptibility for Metabolic Syndrome in Pediatric Transplant Recipients – A Case-Control Study
Introduction. Metabolic syndrome not only contributes to an increased risk for cardiovascular sequelae but is also associated with impaired graft function and lower graft survival…2018 American Transplant Congress
Disparities in Re-Transplantation among Pediatric Renal Transplant Recipients with Graft Failure
Background: While gender and racial disparities in access to transplantation have been reported among pediatric patients, few studies have investigated if these disparities exist in…2018 American Transplant Congress
Immunoglobulin Replacement Therapy in Pediatric Renal Transplant Patients
University of Iowa Hospitals and Clinics, Iowa City, IA.
Immunoglobulin replacement therapy decreases infection frequency in patients with primary immunodeficiency; however, there is limited data regarding the use of intravenous immunoglobulin (IVIG) or subcutaneous…2018 American Transplant Congress
Prediction of Hepatocellular Carcinoma Recurrence Following Liver Transplantation Using Combined Differential Gene Expression, Copy Number Variation and Somatic Mutation Analysis
Liver allocation for transplant candidates with hepatocellular carcinoma is limited by OPTN policy to patients whose tumors remain within size limits defined by Milan criteria.…2018 American Transplant Congress
Comparison of No Kasai Portoenterstomy to Failed Kasai: Analysis of UNOS Database
Texas Children's Hospital/Baylor College of Medicine, Houston.
IntroductionInfants with biliary atresia (BA) identified “later” (typically after 90 days of life) present a management challenge, as late Kasai portoenterostomy (KP) has high failure…2018 American Transplant Congress
Efficacy and Safety of Immediate- and Prolonged-Release Tacrolimus in De Novo Pediatric Transplantation: Randomized Study
This study assessed long-term efficacy/safety of prolonged-release tacrolimus (PR-T) vs immediate-release tacrolimus (IR-T) in de novo pediatric transplant pts. Phase II, parallel-group, multicenter, open-label study…
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 211
- Next Page »